Stifel

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Stifel and other ETFs, options, and stocks.

About SF

Stifel Financial Corp. provides securities brokerage, investment banking, trading, investment advisory, and related financial services. It operates through the following segments: Global Wealth Management, Institutional Group, and Other. 

CEO
Ronald James Kruszewski
CEORonald James Kruszewski
Employees
9,000
Employees9,000
Headquarters
St. Louis, Missouri
HeadquartersSt. Louis, Missouri
Founded
1890
Founded1890
Employees
9,000
Employees9,000

SF Key Statistics

Market cap
10.24B
Market cap10.24B
Price-Earnings ratio
12.47
Price-Earnings ratio12.47
Dividend yield
1.90%
Dividend yield1.90%
Average volume
1.12M
Average volume1.12M
High today
$69.23
High today$69.23
Low today
$66.91
Low today$66.91
Open price
$68.74
Open price$68.74
Volume
1.37M
Volume1.37M
52 Week high
$89.83
52 Week high$89.83
52 Week low
$66.91
52 Week low$66.91

Stock Snapshot

The current Stifel(SF) stock price is $67.80, with a market capitalization of 10.24B. The stock trades at a price-to-earnings (P/E) ratio of 12.47 and offers a dividend yield of 1.90%.

As of 2026-10-15, Stifel(SF) stock has fluctuated between $66.91 and $69.23. The current price stands at $67.80, placing the stock +1.3% above today's low and -2.1% off the high.

The Stifel(SF)'s current trading volume is 1.37M, compared to an average daily volume of 1.12M.

During the past year, Stifel(SF) stock moved between $66.91 at its lowest and $89.83 at its peak.

During the past year, Stifel(SF) stock moved between $66.91 at its lowest and $89.83 at its peak.

SF News

TipRanks 3d
Stifel Financial price target lowered to $78 from $84 at TD Cowen

TD Cowen lowered the firm’s price target on Stifel Financial (SF) to $78 from $84 and keeps a Hold rating on the shares. The firm adjusted targets in the tradit...

Quartz 6d
City Therapeutics is seeking up to $185 million in a U.S. IPO for its gene-silencing drugs - Quartz

...

City Therapeutics is seeking up to $185 million in a U.S. IPO for its gene-silencing drugs - Quartz

Analyst ratings

67%

of 9 ratings
Buy
33.3%
Hold
66.7%
Sell
0%

People also own

Based on the portfolios of people who own SF. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.